自身免疫性肝炎患者双歧杆菌相对丰度呈疾病特异性下降
该研究对347例受试者(AIH 72例、健康对照95例、PBC 99例、UC 81例)粪便16S rRNA基因V1-V2区测序,发现AIH患者菌群多样性降低且双歧杆菌相对丰度呈疾病特异性下降,后者与未获缓解相关(P<0.001)。
要点
- AIH患者肠道菌群多样性较健康对照降低(P=0.016),硫唑嘌呤可部分逆转(P=0.011)。
- 双歧杆菌相对丰度在AIH中呈疾病特异性下降,且与未达缓解相关(P<0.001)。
- 菌群特征区分AIH与PBC的AUC在训练队列为0.787、外部验证队列为0.849。
核心结论
- AIH患者存在疾病特异性粪便菌群改变,以双歧杆菌相对丰度下降为特征,并与疾病活动度增加相关。
研究设计与样本
- 对347例受试者粪便样本行16S rRNA基因V1-V2可变区测序,包括AIH 72例、健康对照95例、原发性胆汁性胆管炎99例和溃疡性结肠炎81例。
主要发现
- AIH患者生物多样性(Shannon熵)较健康对照降低(P=0.016),硫唑嘌呤可部分逆转(P=0.011)。
- AIH患者与健康对照、PBC和UC个体样本间多样性均分离(所有P=0.001)。
- 与健康对照相比,AIH患者Faecalibacterium等厌氧菌属相对丰度降低,Veillonella及兼性厌氧的Streptococcus和Lactobacillus增加。
- AIH患者双歧杆菌相对丰度呈疾病特异性下降,缺乏双歧杆菌与未能达到AIH缓解相关(P<0.001)。
- 双歧杆菌丰度与平均蛋白质摄入量相关(P<0.001);随机森林分类区分AIH与PBC的AUC在训练队列为0.787、外部验证队列为0.849。
临床怎么用
- AIH患者可关注肠道菌群状态,双歧杆菌相对丰度下降或提示疾病活动及缓解失败风险。
- 菌群特征(AUC 0.787/0.849)或有助于AIH与PBC的鉴别,但需进一步验证。
- 双歧杆菌丰度与蛋白质摄入相关,提示饮食干预可能是潜在调节靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The pathogenesis of autoimmune hepatitis (AIH) is poorly understood and little is known about enteric microbiota in AIH. AIM: To investigate disease-specific microbiome alterations in AIH. METHODS: The V1-V2 variable regions of the 16S rRNA gene were sequenced in faecal samples from 347 patients with AIH and controls (AIH n = 72, healthy controls (HC) n = 95, primary biliary cholangitis (PBC) n = 99 and ulcerative colitis (UC) n = 81). RESULTS: Biodiversity (Shannon entropy) was decreased in AIH patients compared to HC (P = 0.016), which was partially reversed by azathioprine (P = 0.011). Regarding between-sample diversity, AIH patients separated from HC, PBC and UC individuals (all P = 0.001). Compared to HC, decreased relative abundance of anaerobic genera such as Faecalibacterium and an increase of Veillonella and the facultative anaerobic genera Streptococcus and Lactobacillus were detected. Importantly, a disease-specific decline of relative abundance of Bifidobacterium was observed in AIH patients. Lack of Bifidobacterium was associated with failure to achieve remission of AIH (P < 0.001). Of potential therapeutic implication, Bifidobacterium abundance correlated with average protein intake (P < 0.001). Random forests classification between AIH and PBC on the microbiome signature yielded an area under receiver operating characteristic curve (AUC) of 0.787 in the training cohort, and an AUC of 0.849 in an external validation cohort. CONCLUSION: Disease-specific faecal microbial alterations were identified in patients with AIH. Intestinal dysbiosis in AIH was characterised by a decline of Bifidobacterium, which was associated with increased disease activity. These results point to the contribution of intestinal microbiota to AIH pathogenesis and to novel therapeutic targets.
引用
- Liwinski T, Casar C, Ruehlemann MC, et al. A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis. Aliment Pharmacol Ther. 2020. PMID: 32383181. doi:10.1111/apt.15754
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。